Skip to main content
PureTech Health plc logo

PureTech Health plc — Investor Relations & Filings

Ticker · PRTC ISIN · GB00BPVG5C82 LEI · 213800LVPDNO2Z9T9I39 IL Manufacturing
Open in API
Filings indexed 1,319 across all filing types
Latest filing 2023-09-28 Regulatory Filings
Country GB United Kingdom
Listing IL PRTC

About PureTech Health plc

https://puretechhealth.com/

PureTech Health is a clinical-stage biotherapeutics company dedicated to discovering, developing, and commercializing new classes of medicine for devastating diseases. The company's research and development engine focuses on advancing novel treatments by enhancing on-target efficacy, improving tolerability, or enabling oral administration of therapeutics with validated mechanisms. Its pipeline includes wholly-owned therapeutic candidates targeting a range of conditions, including idiopathic pulmonary fibrosis, neuropsychiatric disorders, and various cancers.

Recent filings

Filing Released Lang Actions
KarXT-invented at PRTC-submitted for FDA Approval
Regulatory Filings Classification · 98% confidence The document is identified by the RNS Number header and the date stamp, indicating it is a regulatory announcement distributed via the RNS system. The content announces that PureTech Health's Founded Entity, Karuna Therapeutics, submitted a New Drug Application (NDA) to the FDA for KarXT. This is a specific corporate event announcement regarding regulatory progress, not a full financial report (like 10-K or IR) or a general earnings release (ER). Since it is a specific corporate update distributed via RNS that doesn't fit into the other specific categories (like DIRS, DIV, MANG, etc.), the most appropriate classification is the general regulatory announcement fallback, RNS.
2023-09-28 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document is an RNS announcement (indicated by 'RNS Number : 9103N') from PureTech Health PLC, dated September 28, 2023. The title explicitly states 'Transaction in Own Shares' and details the purchase of 52,952 ordinary shares as part of a 'Share Buyback Programme'. This directly corresponds to the definition of a company reporting the repurchase or sale of its own shares. Therefore, the correct classification is 'Transaction in Own Shares' (POS).
2023-09-28 English
PRTC Names Robert Lyne as Chief Portfolio Officer
Board/Management Information Classification · 98% confidence The document is a formal announcement released via RNS (RNS Number: 7523N) on September 27, 2023. The title explicitly states: "PureTech Announces the Appointment of Robert Lyne as Chief Portfolio Officer." This content directly relates to a change in senior management/board composition. According to the definitions, this corresponds to Board/Management Information (MANG). Although it is distributed via RNS, the specific content is not a general regulatory filing but a specific personnel announcement, making MANG the most accurate classification over the general RNS fallback.
2023-09-27 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title: "Transaction in Own Shares" and references a "Share Buyback Programme." It details the date of purchase, number of shares purchased, and the prices paid, followed by a table listing individual transactions. This content directly corresponds to the definition of a report detailing the company buying back or selling its own shares. Therefore, the correct classification is Transaction in Own Shares (POS).
2023-09-27 English
Transaction in Own Shares
Transaction in Own Shares Classification · 100% confidence The document explicitly states its purpose in the title section: "PureTech Health PLC Transaction in Own Shares". It details the purchase of ordinary shares as part of a "Share Buyback Programme" on a specific date (25 September 2023), including volume, high, low, and VWAP prices. This directly corresponds to the definition of a Transaction in Own Shares (Share Repurchase/Issuance). This matches filing type code POS.
2023-09-26 English
Transaction in Own Shares
Transaction in Own Shares Classification · 99% confidence The document explicitly states it is an announcement regarding a 'Transaction in Own Shares' as part of a 'Share Buyback Programme'. It details the date of purchase (22 September 2023), the number of shares purchased, and the price range. This directly matches the definition for 'Transaction in Own Shares' (Code: POS). The document is short and focused on this specific transaction, not a comprehensive financial report or a general regulatory filing.
2023-09-25 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.